CPRX - Catalyst Pharmaceuticals EPS beats by $0.31 misses on revenue
Catalyst Pharmaceuticals (CPRX): Q3 GAAP EPS of $0.41 beats by $0.31.Revenue of $29.32M (-5.1% Y/Y) misses by $2.18M.Cash and equivalents and investments of $127.1M and no funded debt.Shares +1.81% AH.Press Release
For further details see:
Catalyst Pharmaceuticals EPS beats by $0.31, misses on revenue